These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7964161)

  • 1. The IL-1 receptor signaling pathway.
    Kuno K; Matsushima K
    J Leukoc Biol; 1994 Nov; 56(5):542-7. PubMed ID: 7964161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling.
    Wiegmann K; Schütze S; Machleidt T; Witte D; Krönke M
    Cell; 1994 Sep; 78(6):1005-15. PubMed ID: 7923351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NFkB activation.
    Kuno K; Sukegawa K; Ishikawa Y; Orii T; Matsushima K
    Int Immunol; 1994 Aug; 6(8):1269-72. PubMed ID: 7981153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction.
    Schütze S; Machleidt T; Krönke M
    J Leukoc Biol; 1994 Nov; 56(5):533-41. PubMed ID: 7964160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low temperatures and hypertonicity do not block cytokine-induced stimulation of the sphingomyelin pathway but inhibit nuclear factor-kappa B activation.
    Andrieu N; Salvayre R; Jaffrézou JP; Levade T
    J Biol Chem; 1995 Oct; 270(41):24518-24. PubMed ID: 7592669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein.
    Hofmeister R; Wiegmann K; Korherr C; Bernardo K; Krönke M; Falk W
    J Biol Chem; 1997 Oct; 272(44):27730-6. PubMed ID: 9346915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acid sphingomyelinase inhibitor SR33557 counteracts TNF-alpha-mediated potentiation of IL-1beta-induced NF-kappaB activation in the insulin-producing cell line Rinm5F.
    Saldeen J; Jaffrézou JP; Welsh N
    Autoimmunity; 2000 Dec; 32(4):241-54. PubMed ID: 11191283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown.
    Schütze S; Potthoff K; Machleidt T; Berkovic D; Wiegmann K; Krönke M
    Cell; 1992 Nov; 71(5):765-76. PubMed ID: 1330325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor.
    Adam-Klages S; Schwandner R; Adam D; Kreder D; Bernardo K; Krönke M
    J Leukoc Biol; 1998 Jun; 63(6):678-82. PubMed ID: 9620659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells.
    Yang Z; Costanzo M; Golde DW; Kolesnick RN
    J Biol Chem; 1993 Sep; 268(27):20520-3. PubMed ID: 8376408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation.
    Cooke EL; Uings IJ; Xia CL; Woo P; Ray KP
    Biochem J; 2001 Oct; 359(Pt 2):403-10. PubMed ID: 11583588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide signalling and the immune response.
    Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
    Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase.
    Lozano J; Berra E; Municio MM; Diaz-Meco MT; Dominguez I; Sanz L; Moscat J
    J Biol Chem; 1994 Jul; 269(30):19200-2. PubMed ID: 8034680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B.
    Johns LD; Sarr T; Ranges GE
    J Immunol; 1994 Jun; 152(12):5877-82. PubMed ID: 8207213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway.
    Adam D; Wiegmann K; Adam-Klages S; Ruff A; Krönke M
    J Biol Chem; 1996 Jun; 271(24):14617-22. PubMed ID: 8663014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.
    Mori K; Stone S; Braverman LE; DeVito WJ
    Endocrinology; 1996 Nov; 137(11):4994-9. PubMed ID: 8895373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B.
    Dbaibo GS; Obeid LM; Hannun YA
    J Biol Chem; 1993 Aug; 268(24):17762-6. PubMed ID: 8349660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
    Katsuyama K; Shichiri M; Marumo F; Hirata Y
    Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of stress-activated protein kinases/c-Jun N-terminal kinases by the p55 tumour necrosis factor receptor does not require sphingomyelinases.
    Adam D; Ruff A; Strelow A; Wiegmann K; Krönke M
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):343-50. PubMed ID: 9657974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373.
    Lieb K; Kaltschmidt C; Kaltschmidt B; Baeuerle PA; Berger M; Bauer J; Fiebich BL
    J Neurochem; 1996 Apr; 66(4):1496-503. PubMed ID: 8627304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.